சிவப்பு ஆய்வகங்கள் லிமிடெட் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Dr Reddy s Labs to launch Covid drug 2-DG at Rs 990 per sachet
asianage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asianage.com Daily Mail and Mail on Sunday newspapers.
Dr Reddy s Laboratories announces commercial launch of Covid-19 drug 2-DG
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Dr Reddy s Laboratories announces commercial launch of COVID-19 drug 2-DG
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Dr Reddy’s to manufacture Baricitinib drug for Covid treatment
The drug baricitinib has received restricted emergency use approval from the CDSCO, for use in combination with Remdesivir for COVID-19 treatment.
By IANS| Updated: 12th May 2021 11:26 am IST entered into a royalty-free, non-exclusive voluntary licensing agreement for the same. (Photo: Company Logo)
Hyderabad: Pharma major Dr. Reddy’s Laboratories Ltd on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of Baricitinib in India.
The drug baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organization (CDSCO), Ministry of Health, India, for use in combination with Remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporea